NASDAQ:SXTC - Nasdaq - VGG2161P1577 - Common Stock - Currency: USD
1.56
-0.03 (-1.89%)
The current stock price of SXTC is 1.56 USD. In the past month the price decreased by -25%. In the past year, price decreased by -81.78%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
LLY | ELI LILLY & CO | 54.29 | 708.16B | ||
JNJ | JOHNSON & JOHNSON | 15.29 | 369.72B | ||
NVO | NOVO-NORDISK A/S-SPONS ADR | 19.6 | 302.74B | ||
NVS | NOVARTIS AG-SPONSORED ADR | 13.51 | 221.76B | ||
AZN | ASTRAZENECA PLC-SPONS ADR | 18.8 | 216.78B | ||
MRK | MERCK & CO. INC. | 10.01 | 196.20B | ||
PFE | PFIZER INC | 7.33 | 133.39B | ||
SNY | SANOFI-ADR | 13.85 | 129.48B | ||
BMY | BRISTOL-MYERS SQUIBB CO | 6.52 | 97.42B | ||
GSK | GSK PLC-SPON ADR | 6.99 | 77.70B | ||
ZTS | ZOETIS INC | 27.18 | 73.00B | ||
HLN | HALEON PLC-ADR | 22.49 | 49.69B |
China Sxt Pharmaceuticals, Inc. operates as a holding company, which engages in the research, development, manufacture, marketing, and sales of traditional Chinese medicine pieces (TCMP). The company is headquartered in Taizhou, Jiangsu and currently employs 75 full-time employees. The company went IPO on 2019-01-04. The firm develops, manufactures and sells three types of TCMP products: advanced TCMP, fine TCMP and regular TCMP, and TCM Homologous Supplements (TCMHS) products. The firm sells its TCMP products under three brand names such as Suxuangtang, Hui Chun Tang and Tong Ren Tang. Most of its products are sold on a prescription basis across China.
CHINA SXT PHARMACEUTICALS IN
178 Taidong Road North
Taizhou JIANGSU 225300 CN
CEO: Feng Zhou
Employees: 75
Phone: 8652386298290
The current stock price of SXTC is 1.56 USD. The price decreased by -1.89% in the last trading session.
The exchange symbol of CHINA SXT PHARMACEUTICALS IN is SXTC and it is listed on the Nasdaq exchange.
SXTC stock is listed on the Nasdaq exchange.
CHINA SXT PHARMACEUTICALS IN (SXTC) has a market capitalization of 1.12M USD. This makes SXTC a Nano Cap stock.
CHINA SXT PHARMACEUTICALS IN (SXTC) currently has 75 employees.
CHINA SXT PHARMACEUTICALS IN (SXTC) has a resistance level at 1.57. Check the full technical report for a detailed analysis of SXTC support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
SXTC does not pay a dividend.
The PE ratio for CHINA SXT PHARMACEUTICALS IN (SXTC) is 0.04. This is based on the reported non-GAAP earnings per share of 40.81 and the current share price of 1.56 USD. Check the full fundamental report for a full analysis of the valuation metrics for SXTC.
The outstanding short interest for CHINA SXT PHARMACEUTICALS IN (SXTC) is 29.86% of its float. Check the ownership tab for more information on the SXTC short interest.
ChartMill assigns a fundamental rating of 3 / 10 to SXTC. SXTC has a medium profitability rating, but doesn't score so well on its financial health evaluation.
Over the last trailing twelve months SXTC reported a non-GAAP Earnings per Share(EPS) of 40.81. The EPS increased by 117.22% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 318.69% | ||
ROA | 18.7% | ||
ROE | 38.54% | ||
Debt/Equity | 0.06 |